Skip to Main Content

Paper Details

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.
J Int Neuropsychol Soc
13
2020
CNS dysfunction, GDS, HAND, HIV, HIV-Associated Brain Abnormalities, HIV-associated neurocognitive disorders, Meyer, NCI, PLWH, Participants, brain abnormalities, choline, creatine, neurocognitive impairment, neuroinflammation, people, substance use disorder
Author NameAffiliation
Christine Fennema-NotestineUniversity of California
Christine Fennema-NotestineUniversity of California
Christine Fennema-NotestineUniversity of California
Christine Fennema-NotestineUniversity of California
Donald FranklinUniversity of California
Anya UmlaufUniversity of California
Robert K HeatonUniversity of California
Ann C CollierUniversity of Washington
Christina M MarraUniversity of Washington
David B CliffordWashington University School of Medicine
Benjamin B GelmanUniversity of Texas Medical Branch
Ned SacktorThe Johns Hopkins University School of Medicine
Susan MorgelloThe Icahn School of Medicine at Mount Sinai
John Allen McCutchanUniversity of California
Scott L LetendreUniversity of California
Scott L LetendreUniversity of California
Igor GrantUniversity of California
Robert K HeatonUniversity of California
  • 1 - 18

Datasets

Release 1.2